Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
JAZZ
#708
Jazz Pharmaceuticals plc - Ordinary Shares
238.0
5
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.46%
Monthly Change
+3.11%
6 month change
+39.52%
Year Change
+70.04%
Previous Close
236.9
7
Open
238.0
5
Low
238.0
5
High
238.0
5
Volume
113
Markets
US Stock Market
Healthcare
Biotechnology
JAZZ
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
61.63 M
60.66 M
60.77 M
61.56 M
62.74 M
62.74 M
Valuation ratios
Enterprise value
11.13 B
9.58 B
11.01 B
13.4 B
15.37 B
17.99 B
Price to earnings ratio
16.87
-15.45
-21.22
-29.11
1 718.64
2 247.73
Price to sales ratio
2.02
1.66
1.97
2.43
2.66
3.47
Price to cash flow ratio
5.14
5.09
5.93
7.65
8.89
11.62
Price to book ratio
0.5
0.41
0.52
2.4
0.72
0.94
Enterprise value to EBITDA ratio
5.09
8.07
10.65
-34.48
8.64
15.51
Profitability ratios
Return on assets %
-0.01
-0.07
0.02
0.02
0.02
0.02
Return on equity %
-0.02
-0.19
0.06
0.05
0.06
0.06
Return on invested capital %
-2.19
-30.51
72.84
11.05
15.06
15.06
Gross margin %
100
100
100
100
100
100
Operating margin %
-6.23
-65.64
5.11
21.25
31.49
31.49
EBITDA margin %
12.14
-49
20.94
76.68
48.46
48.46
Net margin %
-10.31
-68.71
22.33
16.98
27.42
27.42
Liquidity ratios
Quick ratio
2.97
1.37
1.44
1.67
1.85
1.85
Current ratio
3.38
1.62
1.65
1.86
2.04
2.04
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.08
0.1
0.1
0.1
0.09
0.09
Solvency ratios
Debt to assets ratio
0.46
0.4
0.38
0.37
0.36
0.36
Debt to equity ratio
1.28
1.17
1.09
1
0.95
0.95
Long term debt to total assets ratio
0.47
0.49
0.47
0.46
0.45
0.45
Long term debt to total equity ratio
1.29
1.45
1.35
1.24
1.18
1.18
Per share metrics
Operating cash flow per share
7.05
1.45
7.7
5.94
6.18
21.28
EBIT per share
-0.92
-11.22
0.93
4.17
5.09
-1.02
EBITDA per share
1.79
-8.37
3.83
15.06
7.84
18.35
Total debt per share
87.51
70.85
70.32
70.98
81.01
65.42
Cash per share
30.53
19.44
21.53
22.83
43.48
43.48
Net current asset value per share
67.69
54.75
60.97
68.32
69.34
69.34
Tangible book value per share
68.46
60.57
64.26
70.82
68.57
68.57
Working capital per share
47.64
20.9
24.05
31.54
35.35
35.35
Book value per share
68.46
60.57
64.26
70.82
68.57
68.57
News
Axsome Begins Phase III Study on Solriamfetol for ADHD in Children
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock
Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Momentum Stock: Should You Buy?
Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?
Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline
HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase
JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor Therapies
JAZZ's Zepzelca Fails to Meet Primary Goal in Lung Cancer Study
Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term
Why Is Jazz (JAZZ) Up 1% Since Last Earnings Report?
Jazz Pharmaceuticals plc (JAZZ) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Momentum Stock